|
US2694711A
(en)
|
1952-12-02 |
1954-11-16 |
American Cyanamid Co |
Quinazolone antimalarial compounds
|
|
US6204261B1
(en)
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
|
JP4926473B2
(ja)
|
2003-03-27 |
2012-05-09 |
協和発酵キリン株式会社 |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
JP2008506761A
(ja)
|
2004-07-22 |
2008-03-06 |
アステックス、セラピューティックス、リミテッド |
プロテインキナーゼ阻害剤としてのチアゾールおよびイソチアゾール誘導体
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
WO2006040966A1
(ja)
|
2004-10-08 |
2006-04-20 |
Astellas Pharma Inc. |
芳香環縮合ピリミジン誘導体
|
|
US20090163521A1
(en)
|
2005-06-28 |
2009-06-25 |
Orchid Research Laboratories Limited |
Novel Pyrazolopyrimidinone Derivatives
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
EP1928865A1
(en)
|
2005-08-17 |
2008-06-11 |
Schering Corporation |
Novel high affinity thiophene-based and furan-based kinase ligands
|
|
HUE035389T2
(en)
|
2006-09-26 |
2018-05-02 |
Celgene Corp |
5-substituted quinazolinone derivatives as anticancer agents
|
|
US20080255161A1
(en)
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
US8703768B2
(en)
|
2010-06-09 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Nitrogen containing heteroaryl compounds
|
|
US8440665B2
(en)
|
2010-07-02 |
2013-05-14 |
Gilead Sciences, Inc. |
Apoptosis signal-regulating kinase inhibitors
|
|
US20120165330A1
(en)
|
2010-12-22 |
2012-06-28 |
Sirtris Pharmaceuticals, Inc. |
Quinazolinone and related analogs as sirtuin modulators
|
|
CA2831978A1
(en)
*
|
2011-03-03 |
2012-09-07 |
Universitat Des Saarlandes |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
|
CN103288771B
(zh)
|
2012-02-29 |
2014-12-03 |
中国中化股份有限公司 |
异噻唑类化合物及其作为杀菌剂的用途
|
|
US9452973B2
(en)
*
|
2012-05-04 |
2016-09-27 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
AU2014205043B2
(en)
|
2013-01-14 |
2018-10-04 |
Deuterx, Llc |
3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
|
CN105524053B
(zh)
*
|
2014-10-19 |
2020-06-05 |
广东东阳光药业有限公司 |
四氢苯并噻吩化合物
|
|
WO2016081522A1
(en)
|
2014-11-17 |
2016-05-26 |
Rhode Island Hospital |
Nanomaterial compositions, synthesis, and assembly
|
|
DK3356345T3
(da)
*
|
2015-09-30 |
2024-02-12 |
Max Planck Gesellschaft |
Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
|
|
EP3404024B1
(en)
|
2016-01-14 |
2020-11-18 |
Kangpu Biopharmaceuticals, Ltd. |
Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications
|
|
KR101870968B1
(ko)
*
|
2016-02-02 |
2018-06-25 |
부산대학교 산학협력단 |
Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도
|
|
MX376202B
(es)
|
2016-08-15 |
2025-03-07 |
Lilly Co Eli |
Compuestos de tiofeno condensado utiles como inhibidores de napi-iib.
|
|
TWI762634B
(zh)
*
|
2017-05-05 |
2022-05-01 |
大陸商上海赫普化醫藥技術有限公司 |
胺基-芳基-苯甲醯胺化合物及其使用方法
|
|
EA202091897A1
(ru)
*
|
2018-02-08 |
2020-10-27 |
Энио Фарма |
Неконденсированные производные тиофена и их применение
|
|
US20210000906A1
(en)
*
|
2018-03-21 |
2021-01-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
|
WO2020041741A1
(en)
|
2018-08-24 |
2020-02-27 |
Terns, Inc. |
Thyroid hormone receptor beta agonist compounds
|
|
MA56457A
(fr)
|
2019-07-02 |
2022-05-11 |
Regeneron Pharma |
Modulateurs de hsd17b13 et leurs procédés d'utilisation
|
|
JP2023537271A
(ja)
|
2020-07-24 |
2023-08-31 |
イニファーム，インク． |
チオフェンｈｓｄ１７ｂ１３阻害剤とその使用
|
|
CN116194440A
(zh)
|
2020-07-24 |
2023-05-30 |
伊尼制药公司 |
喹唑啉酮hsd17b13抑制剂及其用途
|
|
IL299972A
(en)
|
2020-08-05 |
2023-03-01 |
Enyo Pharma |
Thiophane compounds for use in the treatment of renal fibrosis
|
|
WO2022040324A1
(en)
|
2020-08-18 |
2022-02-24 |
Metrea Biosciences, Inc. |
COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13
|
|
MX2023003677A
(es)
|
2020-09-30 |
2023-06-22 |
Fl2022 001 Inc |
Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
|
|
US20240083861A1
(en)
|
2020-09-30 |
2024-03-14 |
Fl2022-001, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
EP4221701A1
(en)
|
2020-09-30 |
2023-08-09 |
FL2022-001, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
US20230416802A1
(en)
|
2020-11-06 |
2023-12-28 |
Inipharm, Inc. |
Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatment
|
|
CN116670118B
(zh)
|
2020-11-13 |
2026-02-06 |
伊尼制药公司 |
二氯苯酚hsd17b13抑制剂及其用途
|
|
EP4319872A4
(en)
|
2021-04-05 |
2025-03-12 |
Inipharm, Inc. |
Thiazole/isothiazole hsd17b13 inhibitors and uses thereof
|
|
US12617772B2
(en)
|
2021-04-05 |
2026-05-05 |
Inipharm, Inc. |
Hydroxypyridine HSD17B13 inhibitors and uses thereof
|
|
CA3229569A1
(en)
|
2021-08-20 |
2023-02-23 |
Enanta Pharmaceuticals, Inc. |
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
|
|
EP4469451A4
(en)
|
2022-01-26 |
2025-12-24 |
Inipharm Inc |
HSD17B13 2-SUBSTITUTE THIAZOLES INHIBITORS AND RELATED USES
|
|
US20250340546A1
(en)
|
2022-06-09 |
2025-11-06 |
Boehringer Ingelheim International Gmbh |
Hsd17b13 inhibitors
|
|
CN118955491A
(zh)
|
2024-09-04 |
2024-11-15 |
广东药科大学 |
一类新型噻唑类hsd17b13抑制剂、其制备方法及其作为药物的用途
|